Design and synthesis of 3,7-diarylimidazopyridines as inhibitors of the VEGF-receptor KDR.
3,7-Diarylsubstituted imidazopyridines were designed and developed as a new class of KDR kinase inhibitors. A variety of imidazopyridines were synthesized and potent inhibitors of KDR kinase activity were identified with good aqueous solubility.